| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/23/2009 | EP2101800A1 Extracts from the skin of fruits of plants from genus vitis, compositions containing the same and a process for its manufacture |
| 09/23/2009 | EP2101795A2 Cellular preparations for use as a revascularisation stimulating agent |
| 09/23/2009 | EP2101783A2 Method of preventing or treating myocardial ischemia |
| 09/23/2009 | EP2101778A2 Agent for treating vascular leaks |
| 09/23/2009 | EP2101777A1 Composition for treating a pulmonary hypertension |
| 09/23/2009 | EP2101775A1 Reduction of cardiovascular symptoms |
| 09/23/2009 | EP2101578A1 Means for the treatment of acute and chronic disorders of cerebral circulation, including insult, based on hydrogenated pyrido (4, 3-b) indoles (variants), pharmacological means based thereon and method for the use thereof |
| 09/23/2009 | EP2101575A2 Ace2 activator compounds and methods of use thereof |
| 09/23/2009 | EP1651213B1 Use of angiotensin ii receptor antagonists, especially telmisartan, in order to increase insulin sensitivity |
| 09/23/2009 | EP1508561B1 2-(a-HYDROXYPENTYL) BENZOATE AND ITS PREPARATION AND USE |
| 09/23/2009 | EP1461038B9 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 09/23/2009 | EP1377288B1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and use |
| 09/23/2009 | CN101538320A Artificial zinc finger protein transcription factor capable of specifically regulating up HO-1 gene expression and application thereof |
| 09/23/2009 | CN101538316A Method for preparing Eptifibatide with solid phase method |
| 09/23/2009 | CN101538314A Method for purifying Eptifibatide |
| 09/23/2009 | CN101538313A Peptide-based compounds |
| 09/23/2009 | CN101538309A Method for extracting ursolic acid from persimmon leaf by composite countercurrent method |
| 09/23/2009 | CN101538306A Preparation method of phytosterin ester rich in oleic acid |
| 09/23/2009 | CN101538300A Salting-out and solvating-out crystallization method for citicoline |
| 09/23/2009 | CN101538299A Method for synthesizing 5,6,4'-trihydroxyflavone-7-O-D-glucuronic acid |
| 09/23/2009 | CN101538297A Preparation method of high-purity monomer flavone and general flavone contained in capsella bursa-pastoris and application of general flavone |
| 09/23/2009 | CN101538293A Method for preparing secoisolariciresinol diglucoside and ferulic acid glucoside or ferulic acid glucoside ethyl ester |
| 09/23/2009 | CN101538254A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme |
| 09/23/2009 | CN101538244A 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
| 09/23/2009 | CN101538238A Polymorphs of atorvastatin tert.-butylester and use as intermediates for the preparation of atorvastatin |
| 09/23/2009 | CN101538218A Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases |
| 09/23/2009 | CN101537190A Peptide-based compounds |
| 09/23/2009 | CN101537188A Pinocembrin and cyclodextrin or cyclodextrin derivative inclusion compound |
| 09/23/2009 | CN101537182A Combination comprising an HMG CoA reductase inhibitor and an insulin secretor enhancer or an insulin sensitizer |
| 09/23/2009 | CN101537181A Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and / or congestive heart failure |
| 09/23/2009 | CN101537130A Chinese traditional medicine preparation for curing hypertensive cerebral hemorrhage |
| 09/23/2009 | CN101537129A Applications of dendrobium nobile lindl alkaloids in medicines prepared for treating ischemic brain damage and product thereof |
| 09/23/2009 | CN101537121A Chinese medicine for treating arteriosclerosis |
| 09/23/2009 | CN101537114A Chinese medicine for treating arrhythmia |
| 09/23/2009 | CN101537101A Drug used for curing liver, limb muscles and pelvic blood vessel tumors and complicating diseases thereof, varicosity of leg and ulcer with hemorrhage and a preparation method thereof |
| 09/23/2009 | CN101537091A Chinese medicinal preparation for treating stroke |
| 09/23/2009 | CN101537077A Chinese medicinal mixed tincture |
| 09/23/2009 | CN101537076A Chinese traditional medicine composition for curing angitis and preparation method thereof |
| 09/23/2009 | CN101537074A Chinese traditional medicine preparation for curing coronary heart disease with angina pectoris |
| 09/23/2009 | CN101537068A Chinese medicine for treating angina |
| 09/23/2009 | CN101537048A Application of buckwheat and bee pollen in preparing drugs and method for preparing capsules and tablets thereby |
| 09/23/2009 | CN101537040A Composite for stimulating acupoint and raising blood pressure |
| 09/23/2009 | CN101537039A Moldavica dragonhead general flavone extract as well as preparation method and application thereof |
| 09/23/2009 | CN101537032A Applications of sappan wood in the preparation of anti-PTCA postoperative restenosis and stent restenosis medicaments |
| 09/23/2009 | CN101537026A Xuesaitong dispersible tablet and preparation method thereof |
| 09/23/2009 | CN101536993A Vitamin D3 microcapsule and preparation method thereof |
| 09/23/2009 | CN101536988A Troxerutin freeze-dried powder injection and preparation method thereof |
| 09/23/2009 | CN101536859A Traditional Chinese medicine health-care pillow and preparation method thereof |
| 09/23/2009 | CN101536715A Orange peel tea bag |
| 09/23/2009 | CN100543022C 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same |
| 09/23/2009 | CN100543016C Intermediate compound of 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives |
| 09/23/2009 | CN100542606C Vaccine composition comprising tumour antigen and adjuvant composition |
| 09/22/2009 | US7592455 potent and selective inhibitors of p38 kinase, especially p38 alpha , p38 beta and p38 beta 2; immune or inflammatory disorders; Ethyl 3-(benzylamino)-6-oxo-7-phenyl-6,7-dihydrothieno[2,3-b]pyridine-2-carboxylate |
| 09/22/2009 | US7592450 used to inhibit proliferative conditions, such as cancer and psoriasis, with improved bioavailability and stability |
| 09/22/2009 | US7592449 Therapy for ischemic-repefusion injuries; liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin |
| 09/22/2009 | US7592350 Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| 09/22/2009 | US7592339 Substituted oxazolidinones and their use in the field of blood coagulation |
| 09/22/2009 | US7591993 Microspheres useful for embolization which comprises polyvinylalcohol. The present invention also relates to an injectable suspension suitable for embolization which comprises the polyvinylalcohol microspheres and a suitable |
| 09/22/2009 | CA2487450C (2s)-2-ethylphenylpropanoic acid derivatives |
| 09/22/2009 | CA2426349C Over-coated chewing gum formulations including tableted center |
| 09/22/2009 | CA2419588C Piperidine derivatives for use 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 09/22/2009 | CA2402121C Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 09/22/2009 | CA2399451C Tyrosine derivatives with anti-leukotriene activity |
| 09/22/2009 | CA2398274C Adenosine receptor modulators |
| 09/22/2009 | CA2360894C (1-phenacyl-3-phenyl-3-piperidylethyl) piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same |
| 09/22/2009 | CA2209640C Cycloalkano-pyridines |
| 09/17/2009 | WO2009114597A1 Apoaequorin-containing compositions and methods of using same |
| 09/17/2009 | WO2009113952A1 Phytol as a cholesterol lowering agent |
| 09/17/2009 | WO2009113743A1 Polyethylene glycolated lactoferrin complex and method of producing the same |
| 09/17/2009 | WO2009113741A2 A combination drug for treating vascular disorder |
| 09/17/2009 | WO2009113560A1 Fused heterocyclic compound |
| 09/17/2009 | WO2009113504A1 Patch |
| 09/17/2009 | WO2009113480A1 Therapeutic agent for cerebral infarction |
| 09/17/2009 | WO2009113420A1 Improvement of dissolvability of preparation containing olmesartan medoxomil |
| 09/17/2009 | WO2009113320A1 Mmp inhibitor |
| 09/17/2009 | WO2009113287A1 Aromatic antihypertensive agent, and method for lowering blood pressure in mammal |
| 09/17/2009 | WO2009112954A2 Processes for the preparation of bosentan and related compounds using novel intermediates |
| 09/17/2009 | WO2009112826A1 Furo [3, 2-b] pyrr0l-3-0nes as cathepsin s inhibitors |
| 09/17/2009 | WO2009112800A1 Losartan composition |
| 09/17/2009 | WO2009112691A2 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof |
| 09/17/2009 | WO2009112651A1 Imidazo[1,2-a]pyridine-2-carboxamide derivatives, preparation thereof and application thereof in therapeutics |
| 09/17/2009 | WO2009112445A1 Method of increasing cellular phosphatidyl choline by dgat1 inhibition |
| 09/17/2009 | WO2009112155A1 Heteroaryl-substituted dicyanopyridines and use thereof for treatment of cardiovascular diseases |
| 09/17/2009 | WO2009111948A1 The salts of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)piperidine-2,6-dione or its derivatives, their polymorphs, preparation methods and uses thereof |
| 09/17/2009 | WO2009111943A1 The compounds as the estrogen related receptors modulators and the uses thereof |
| 09/17/2009 | WO2009093916A3 Derivatives of aminoalkanols, method of obtaining aminoalkanols and their use |
| 09/17/2009 | WO2009085766A3 Fenofibric acid amorphous dispersion; method of making; and method of use thereof |
| 09/17/2009 | WO2009046867A3 Caerulein alone or in combination with acth (3-24 ) as therapeutic agent |
| 09/17/2009 | WO2009046866A3 Trap-14 as a therapeutic agent |
| 09/17/2009 | WO2009040070A3 Use of helodermin as a therapeutic agent |
| 09/17/2009 | WO2009027785A3 1, 3-oxazole derivatives as cetp inhibitors |
| 09/17/2009 | US20090233991 Generation of biological pacemaker activity |
| 09/17/2009 | US20090233990 Generation of biological pacemaker activity |
| 09/17/2009 | US20090233977 Method of Treating Atherosclerosis, dyslipidemias and related conditions |
| 09/17/2009 | US20090233971 GSK-3 Inhibitors |
| 09/17/2009 | US20090233955 1H-Pyrrolo[2,3-B]Pyridnes |
| 09/17/2009 | US20090233951 Parenteral solutions containing metolazone |
| 09/17/2009 | US20090233949 Isoserine derivatives for use as coagulation factor ixa inhibitors |
| 09/17/2009 | US20090233946 Fused heteroaryl pyridyl and phenyl benzenesuflonamides as ccr2 modulators for the treatment of inflammation |
| 09/17/2009 | US20090233920 Organic compounds |